Objective-To study the effect of sympathetic stimulation and increase in heart rate on the QT and QTc intervals. Design-Prospective non-randomised study of eight consecutive patients. Setting-Electrophysiology laboratory at a tertiary centre. Patients-Eight patients aged 10-20 years (median 12.5) undergoing repeat electrophysiological study after previously successful catheter ablation (n = 6) or presumed supraventricular tachycardia (n = 2) with negative studies. (median 12-5 years) (six boys) were prospectively studied during electrophysiological (EP) evaluation. Six patients had previously undergone successful radiofrequency catheter ablation for supraventricular tachycardia, and the other two had EP studies for presumed supraventricular tachycardia but were found to be normal. All had normal cardiac structure by echocardiography. None had inducible arrhythmia at the time of the present study. Those who underwent ablations had their procedure performed through the atrial approach, and no lesions were placed on the ventricular myocardium. A previous study from our laboratory had shown no change in the repolarisation time (as measured by JT interval) in patients with WolffParkinson-White syndrome after successful ablation.5 Also, for this study, we used each patient as his or her own control. Informed consent was obtained from all parents of patients before the EP study.
Previous reports on the effect of alterations of heart rate on the QT interval in adults have shown conflicting results. While some' have seen a direct effect of heart rate on the QT interval, others2A have seen no such effect. The subject has gone largely unremarked in children and adolescents. We evaluated the effect of atrial pacing and ,B adrenergic stimulation on the QT and QTc intervals in a group of children and adolescents.
Patients and methods

PATIENTS
Eight patients aged 10-20 years (median years) (six boys) were prospectively studied during electrophysiological (EP) evaluation. Six patients had previously undergone successful radiofrequency catheter ablation for supraventricular tachycardia, and the other two had EP studies for presumed supraventricular tachycardia but were found to be normal. All had normal cardiac structure by echocardiography. None had inducible arrhythmia at the time of the present study. Those who underwent ablations had their procedure performed through the atrial approach, and no lesions were placed on the ventricular myocardium. A previous study from our laboratory had shown no change in the repolarisation time (as measured by JT interval) in patients with WolffParkinson-White syndrome after successful ablation.5 Also, for this study, we used each patient as his or her own control. Informed consent was obtained from all parents of patients before the EP study.
Twelve-lead electrocardiograms (ECG) were obtained at resting baseline and during right atrial pacing at 133 beats/min (cycle length 450 ms). An isoprenaline infusion was then begun at a dose of 0-025 ,g/kg/min. After an interval of about 5 min, when the heart rate was seen to have stabilised, a 12-lead ECG was obtained. Right atrial pacing was then performed again at the rate of 133 beats/min and, once again, after an interval of 5 min to allow stabilisation, another ECG was obtained. Finally, the dose of isoprenaline was increased to 0 05 ,ug/kg/min and, after stabilisation of heart rate, another ECG was performed. Pacing was not performed at the 0 05 ug/kg/min dose because the heart rate was often faster than 133 beats/min.
The ECG recordings were obtained at normal filtering (0-100 Hz) run at 50 mm/s paper speed. In each recording, the RR interval and the QT interval were measured by hand, using calipers in six consecutive beats, and the mean value was calculated. The QT was measured in lead II as recommended by Moss et al. 6 The QTc was calculated using Bazett's formula:
QTc= QT 
VRR STATISTICAL ANALYSIS
The data were analysed using analysis of variance (ANOVA) for repeated measures. If significance was noted, further analysis was performed by paired t testing. A P value < 0-05 was considered significant.
Results
The A significant shortening of the QT interval was noted at each manoeuvre compared with the baseline QT value. A significant simultaneous prolongation of the QTc was also noted. Furthermore, the RR interval with 005 pg/kg/min of isoprenaline was nearly 450 ms. Nevertheless, the QT interval was similar with isoprenaline and with pacing alone at 450 ms. Thus at comparable heart rates, the QT and QTc were similar, whether the heart rate was achieved by pacing or by isoprenaline.
Discussion
Our study showed that heart rate directly influences the QT interval in children and adolescents. Previous studies on this subject in adults have shown conflicting results.
Ahnve and Vallin showed that heart rate can independently influence the QT interval, regardless of the presence of catecholamines.'
In their study, they used pacing and / blockade to determine the effect of heart rate.'
Browne et al found that vagolytic drugs such as atropine can influence the QT interval, regardless of the heart rate.' Rickards and Norman found that exercise-induced shortening of the QT interval was secondary to factors extrinsic to the heart rate.' In their study, patients paced at rates comparable to physiological exercise showed only a small decrease in the QT interval. This was the rationale for the QT interval being used as a sensor for rateresponsive pacing.
Our results are more in keeping with those of Ahnve and Vallin.' The QT interval was shortened by pacing at 450 ms. Isoprenaline at a small dose (0.025 yg/kg/min) shortened the QT interval to a comparable level. Superimposition of pacing at 450 ms on to this small dose of isoprenaline did not lead to further shortening of the QT interval. So, at comparable fast heart rates, the QT interval was similar regardless of whether isoprenaline or pacing or a combination of the two caused that heart rate. Thus our study shows that heart rate probably directly influences the QT interval.
The diagnosis of long QT syndrome can sometimes be difficult if the QTc is in the borderline range. Shimizu et al showed that manoeuvres that increase the heart rate can be used to differentiate patients with long QT syndrome from those without.7 Recently, Vetter et al studied children with and without long QT syndrome.8 They showed that the QTc is prolonged by isoprenaline in patients with long QT syndrome who had a borderline QT (and QTc) on the resting ECG, whereas the QTc interval was not prolonged in normal patients. A similar response was also seen during atrial pacing in the two sets of patients. Our study shows that the QTc can be prolonged, even in children and adolescents, both by pacing and by isoprenaline. We believe that the QTc is prolonged secondary to the excessive heart rate effect of pacing and isoprenaline, which reduces the denominator in Bazett's equation. We believe, therefore, that to rely solely on QTc could lead to an erroneous diagnosis of long QT syndrome in patients with borderline QT and QTc.
Yet another implication of our study is in the use of rate-responsive pacemakers that have QT sensors. If heart rate alone can lead to shortening of the QT interval, this may lead to a positive feedback situation with unnecessary heart rate acceleration if a QT sensor is used. Further studies are required to clarify this issue before the use of the QT sensing as a viable means of rate-responsive pacing in children and adolescents.
In summary, we conclude that children and adolescents show a shortening of the QT and prolongation of QTc intervals with manoeuvres that increase heart rate, such as atrial pacing or isoprenaline. This response should be borne in mind when such manoeuvres are performed in individuals with a suspected diagnosis of long QT syndrome. 
